4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-091440
Chief Medical Officer sold 6,461 shares at $14.58 ($94,205)
From the SEC's structured data for this filing
Trades in this filing
Bedrosian Camille L · Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-02 | Sale : show line 1 in the form | −6,461 | $14.58 | $94,205 | 169,295 | D |
| Open-market sales · 6,461 sh · avg $14.58 · $94,205 | ||||||
Loading xslF345X05/ownership.xml…